Wetenschappelijke publicaties van Bordet

C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect.
Auteurs Schoenauen L, Stubbe FX, Van Gestel D, Penninckx S, Heuskin AC
Auteurs (entité) Penninckx Sébastien
Revue Clin Transl Radiat Oncol
Date de publication 2024-03

C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect.

C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect.
Auteurs Schoenauen L, Stubbe FX, Van Gestel D, Penninckx S, Heuskin AC
Auteurs (entité) VAN GESTEL DIRK
Revue Clin Transl Radiat Oncol
Date de publication 2024-03

C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.
Auteurs Pop CF, Veys I, Bormans A, Larsimont D, Liberale G
Auteurs (entité) VEYS ISABELLE
Revue Breast Cancer Res Treat
Date de publication 2024-01

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.
Auteurs Pop CF, Veys I, Bormans A, Larsimont D, Liberale G
Auteurs (entité) LIBERALE GABRIEL
Revue Breast Cancer Res Treat
Date de publication 2024-01

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.
Auteurs Pop CF, Veys I, Bormans A, Larsimont D, Liberale G
Auteurs (entité) LARSIMONT DENIS
Revue Breast Cancer Res Treat
Date de publication 2024-01

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
Auteurs Mileva M, de Vries EGE, Guiot T, Wimana Z, Deleu AL, Schröder CP, Lefebvre Y, Paesmans M, Stroobants S, Huizing M, Aftimos P, Tol J, Van der Graaf WTA, Oyen WJG, Vugts DJ, Menke-van der Houven van Oordt CW, Brouwers AH, Piccart-Gebhart M, Flamen P, Gebhart G
Auteurs (entité) DELEU ANNE-LEEN
Revue NPJ Breast Cancer
Date de publication 2024-01

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
Auteurs Mileva M, de Vries EGE, Guiot T, Wimana Z, Deleu AL, Schröder CP, Lefebvre Y, Paesmans M, Stroobants S, Huizing M, Aftimos P, Tol J, Van der Graaf WTA, Oyen WJG, Vugts DJ, Menke-van der Houven van Oordt CW, Brouwers AH, Piccart-Gebhart M, Flamen P, Gebhart G
Auteurs (entité) PICCART MARTINE
Revue NPJ Breast Cancer
Date de publication 2024-01

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
Auteurs Mileva M, de Vries EGE, Guiot T, Wimana Z, Deleu AL, Schröder CP, Lefebvre Y, Paesmans M, Stroobants S, Huizing M, Aftimos P, Tol J, Van der Graaf WTA, Oyen WJG, Vugts DJ, Menke-van der Houven van Oordt CW, Brouwers AH, Piccart-Gebhart M, Flamen P, Gebhart G
Auteurs (entité) FLAMEN PATRICK
Revue NPJ Breast Cancer
Date de publication 2024-01

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
Auteurs Mileva M, de Vries EGE, Guiot T, Wimana Z, Deleu AL, Schröder CP, Lefebvre Y, Paesmans M, Stroobants S, Huizing M, Aftimos P, Tol J, Van der Graaf WTA, Oyen WJG, Vugts DJ, Menke-van der Houven van Oordt CW, Brouwers AH, Piccart-Gebhart M, Flamen P, Gebhart G
Auteurs (entité) GEBHART GERALDINE
Revue NPJ Breast Cancer
Date de publication 2024-01

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Erasmusziekenhuis

Bekijk alle wetenschappelijke publicaties van Erasmus

Wetenschappelijke publicaties van Erasmus

Queen Fabiola Kinderziekenhuis

Bekijk alle wetenschappelijke publicaties van het Koningin Fabiola Kinderziekenhuis

Wetenschappelijke publicaties van het Koningin Fabiola-Kinderziekenhuis

Jules Bordet-instituut

Bekijk alle wetenschappelijke publicaties van Jules Bordet

Wetenschappelijke publicaties van Jules Bordet

Wetenschappelijke publicaties van Bordet

Wetenschappelijke publicaties van Bordet

<i>C. elegans</i>: A potent model for high-throughput screening experiments investigating the FLASH effect.

<i>C. elegans</i>: A potent model for high-throughput screening experiments investigating the FLASH effect.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Erasmusziekenhuis

Queen Fabiola Kinderziekenhuis

Jules Bordet-instituut

Wetenschappelijke publicaties van Bordet

Wetenschappelijke publicaties van Bordet

<i>C. elegans</i>: A potent model for high-throughput screening experiments investigating the FLASH effect.

<i>C. elegans</i>: A potent model for high-throughput screening experiments investigating the FLASH effect.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Erasmusziekenhuis

Queen Fabiola Kinderziekenhuis

Jules Bordet-instituut

Search for a keyword

Please select a hospital